Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 12 |  Ricks David ADirector, President, Chair, and CEO |  LLYELI LILLY & CoGift | G | — 23.5K sh |
| Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Dec Timothy CSenior Vice-President & CFO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,500 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Burchianti RalphDirector |  CBFVCB Financial Services, Inc.Option exercise | M | $74K 2,810 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 60.4K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 169.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | DeLucchi Graziano Angelo Giovanni PasquinoDirector |  USGOU.S. GoldMining Inc.Grant or award | A | $57K 10.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 205.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,750 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 100.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,250 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Rubin JonathanSVP, Chief Medical Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,977 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,252 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Gemayel GeorgesDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,613 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 331.7K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 958.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 4,977 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 8,252 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,905 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 2,989 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Ludwig Jeffrey G.Director, President & CEO |  MSBIMidland States Bancorp, Inc.Tax withholding | F | $93K 2,814 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 12 | Peabody MarkExecutive VP & Pres-Aerospace |  ATROASTRONICS CORPOption exercise | M | $128K 4,820 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Singh SumitDirector, Chief Executive Officer |  CHWYChewy, Inc.Open-market sale · 10b5-1 plan | SELL | $492K 23.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Hudson Frederick M.Director | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 7,296 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Barlow CarroleeDirector | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 9,305 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 25.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $23K 208 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Comly Barbara J.EVP, GC & Corporate Secretary | MIAXMIAMI INTERNATIONAL HOLDINGS, INC. Open-market sale · 10b5-1 plan | SELL | $819K 23.3K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Khattar Jack A.Director, President, CEO | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 200.0K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 3,375 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 12 | Mottola FrankSVP, Chief Tech. Ops. Officer | SUPNSUPERNUS PHARMACEUTICALS, INC. Other acquisition or disposition | J | — 19.5K sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Maetzold Derek JDirector, Pres. & Chief Exec. Officer |  CSTLCASTLE BIOSCIENCES INCOpen-market sale · 10b5-1 plan | SELL | $38K 1,025 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Bernstein David CChief Accounting Officer |  ABNBAirbnb, Inc.Open-market sale · 10b5-1 plan | SELL | $294K 1,756 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | van Houte HansChief Financial Officer |  NRIXNurix Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $24K 1,469 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 11 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner |  PACSPACS Group, Inc.Open-market sale · 10b5-1 plan | SELL | $235K 5,080 sh | Nov 4, 2026 traded Nov 3, 2026 |
| 11 | Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER |  MIRMMirum Pharmaceuticals, Inc.Option exercise · 10b5-1 plan | M | — 20.0K sh | Nov 4, 2026 traded Nov 4, 2026 |
| 11 | Tsao DavidDirector, Chief Technology Officer | BLLNBillionToOne, Inc. Open-market sale · 10b5-1 plan | SELL | $98K 917 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Hall John TDirector, Chief Executive Officer |  INTAIntapp, Inc.Open-market sale · 10b5-1 plan | SELL | $54K 1,200 sh | Nov 4, 2026 traded Nov 2, 2026 |
| 11 | Lewis Michelle ReneeChief Accounting Officer | PACSPACS Group, Inc. Open-market sale · 10b5-1 plan | SELL | $159K 3,172 sh | Nov 4, 2026 traded Nov 4, 2026 |
| 11 | Hasson Heather L.Director, Executive Chairman, 10% Owner |  FIGSFIGS, Inc.Tax withholding | F | $642K 30.1K sh | Nov 4, 2026 traded Nov 2, 2026 |
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K